Developer docs
API playgroundTry for free, no card

Search company profiles

XPANCEO

Full company profile

uuid00005hr

Namestring
XPANCEO
Legal namestring
XPANCEO Research On Natural Science L.L.C. S.O.C.
Websiteurl
xpanceo.com
Company typeenum
Private
Founded yearint
2021
Descriptiontext

XPANCEO is a Dubai-headquartered deep-tech company, founded in 2021 by Roman Axelrod and Dr. Valentyn S. Volkov, that is developing a smart contact lens as a single invisible computing platform integrating AR/XR display, biometrics, biosensing, night vision, color correction, and wireless power. Its technical stack combines proprietary 2D/quasi-2D gold transparent conductors, van der Waals and 2D nanophotonic materials, electrochemical tear-fluid biosensors, a custom high-efficiency on-body antenna paired with a compact companion device, and an integrated solid-state microbattery co-developed with France-based ITEN. On top of the platform architecture, XPANCEO is fielding standalone application lenses for glaucoma management (with an AI model trained on 10,000+ IOP measurements), medicine-level tear diagnostics for cancer and thrombosis, holographic AR vision for frontier environments, color-blindness correction, biometric authentication, passive moiré-pattern eye-tracking (~0.3° precision), and an intracorneal retinal projection implant co-developed with Italy-based INTRA-KER for corneal-blindness patients.

The company is currently pre-revenue, with commercial sales not yet started. Go-to-market is event-driven (MWC Barcelona, VivaTech Paris, GITEX Global Dubai, GITEX AI Europe Berlin) and partnership-driven in the near term, with a planned B2B/enterprise motion first targeting medical, aerospace, defense, and industrial customers by 2028, followed by a direct-to-consumer launch of the all-in-one smart contact lens in the early 2030s (most recently cited as 2033–2035). XPANCEO has raised $290 million across two rounds (a $40M seed in October 2023 and a $250M Series A in July 2025, both led by Opportunity Venture (Asia)) at a $1.35 billion unicorn valuation, employs 100+ scientists and engineers (more than half PhDs), and has filed 50+ patent applications alongside 300+ peer-reviewed publications. A Scientific Advisory Board chaired by Nobel Laureate Sir Konstantin Novoselov provides scientific oversight, and a multi-stage validation collaboration with the Mohammed Bin Rashid Space Centre (MBRSC) is underway.

Short descriptiontext

XPANCEO is a Dubai-based deep-tech company developing a smart contact lens that fuses AR display, biometric biosensing, wireless power, and AI into a single invisible computing platform, currently targeting medical, aerospace, defense, and industrial enterprise customers with planned consumer availability in the early 2030s.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersDubai, United Arab Emirates
HQ citystring
Dubai
HQ countrystring
United Arab Emirates
HQ regionstring
Middle East
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
smart contact lenses, augmented reality wearables, nanophotonic optics, tear-fluid biosensing, extended reality computing
Industry6 codes
PRIMARYHLAHAJAE
Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLAHAJAF
Dry Eye & Ocular Surface Devices (Meibography, Tear Osmolarity, IPL, Thermal Pulsation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLAHAJAI
Glaucoma Diagnostics & Surgical Devices (Tonometry, Gonioscopy, MIGS, Drainage Implants, Laser Trabeculoplasty)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLAHAJAN
Low Vision & Assistive Vision Devices (Magnifiers, Electronic Video Magnifiers, Wearable Vision Aids)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHDACALAH
Wearable Computers (Industrial Smart Glasses/Wrist/Arm-Mount)
SECONDARYIMAGAJAF
Optoelectronic Components (LEDs, photodiodes, optocouplers, optical sensors)
Industrials, Manufacturing & Construction/Electrical Equipment & Industrial Electronics/Electronic Components for Industrial Applications (Passive/active components, industrial-grade modules)
NAICS code2 codes
  • Ophthalmic Goods Manufacturing339115
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code4 codes
  • Ophthalmic Goods3851
  • Optical Instruments & Lenses3827
  • Electromedical & Electrotherapeutic Apparatus3845
  • Measuring & Controlling Devices, Nec3829
Product category
Smart Contact Lens Wearables
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model3 records
1Future hardware sales (smart contact lenses)
TypeHardware Sales
Description

Primary planned future revenue stream via direct sale of smart contact lenses integrating AR/XR display, biometric health monitoring, night vision, zoom, and wireless charging. B2B business customers targeted by 2028 and broad consumer launch planned for the early 2030s (originally ~2030, later refined to 2033–2035 per company statements). XPANCEO is currently pre-revenue.

xpanceo.com
2Future intracorneal implant sales (with INTRA-KER)
TypeHardware Sales
Description

Future revenue opportunity from the XPANCEO/INTRA-KER intracorneal implant that projects images directly onto the retina for patients with corneal blindness. Estimated addressable market of $50–200 million annually, with planned clinical trials over the next two years.

xpanceo.com
3Licensing / IP out-licensing (potential)
TypeLicensing Royalties
Description

Long-term revenue potential from licensing the company's patent portfolio (50+ patents applied, including WO2024102024A1 on wearable optical devices and quasi-2D gold conductors) and underlying 2D-material/nanophotonic IP to adjacent industries. Currently pre-commercial.

xpanceo.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

XPANCEO develops an invisible, weightless smart contact lens platform that fuses five core enabling modules (on-eye microdisplay with proprietary optics, communication/companion module with custom high-efficiency antenna, solid-state microbattery with wireless recharging, electrochemical tear-fluid biosensing, and quasi-2D gold transparent flexible electronics) into a single AI-powered XR computing platform. On top of the platform, the company offers standalone smart contact lens applications for glaucoma management, medicine monitoring, AR vision in frontier environments, color correction, authentication, space operations, and passive eye-tracking, plus an intracorneal implant co-developed with INTRA-KER for corneal blindness patients.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

XPANCEO's offering is a platform-plus-modules architecture built around a single integrated smart contact lens — described as the ultimate invisible computing platform for the AI era — into which five core enabling technology modules are combined: the Microdisplay for Smart Contact Lenses (AR image projection), the Communication Module / Compact Companion (high-efficiency wireless data link and power management), the Microbattery (autonomous solid-state power with wireless recharging, co-developed with ITEN), the Health Monitoring Platform (electrochemical tear-fluid biosensing), and the Transparent Flexible Electronics (quasi-2D gold conductors). On top of this platform XPANCEO offers a portfolio of standalone, ready-to-deploy smart contact lens applications — the AI-powered Smart Contact Lens for Glaucoma Management, the Smart Contact Lens for Medicine Monitoring, the AR Vision Smart Contact Lens for Frontier Applications, the Smart Contact Lens for Color Correction, the Smart Contact Lens for Authentication, the Space-Ready Smart Contact Lens, and the Passive Eye-Tracking Smart Contact Lens — each addressing a specific high-value use case. The company has additionally co-developed an Intracorneal Implant with INTRA-KER for corneal-blindness patients, extending the same microdisplay and wireless protocols into a surgically implantable form factor. The integrated on-eye prototype combining display, power, connectivity, and sensing is scheduled for first public demonstration in early 2027, with business customers targeted by 2028 and consumer products projected for the early 2030s.

Product and service9 records
1Smart Contact Lens Platform (XPANCEO Invisible Computing Platform)
Categorycore platform
Description

Unifying platform that combines the microdisplay, communication module, microbattery, health monitoring platform, and transparent flexible electronics into a single smart contact lens designed as the invisible computing platform for the AI era, integrating AR vision, real-time biometrics, wireless power, and AI.

2Smart Contact Lens for Glaucoma Management
Categorystandalone application
Description

AI-powered smart contact lens with an embedded intraocular pressure (IOP) optical-pattern sensor; users capture the pattern with a smartphone AI app to instantly assess eye pressure for continuous at-home glaucoma monitoring.

3Smart Contact Lens for Medicine Monitoring
Categorystandalone application
Description

Smart contact lens that, after a full day of wear, is placed in a container using advanced spectroscopy with custom-developed gold nanoparticles to detect medication traces in tear fluid without an invasive blood test, supporting personalized dosing in cancer and thrombosis therapies.

4AR Vision Smart Contact Lens for Frontier Applications
Categorystandalone application
Description

Smart contact lens with a holographic optical element paired with a helmet-mounted external image source, designed for space missions, aviation, and racing where face-worn devices are impractical; allows the eye to focus on the image without obstructing vision.

5Smart Contact Lens for Color Correction
Categorystandalone application
Description

Smart contact lens enhanced with specially developed 2D-material-based nanoparticles that help people with color blindness distinguish RGB spectra by modifying the optical properties of incoming light.

6Smart Contact Lens for Authentication
Categorystandalone application
Description

Demo smart contact lens supporting transaction authentication, retail and financial services verification, universal system access (vehicles, buildings, terminals), and credential verification for age & access validation, esports compliance, and critical ops clearance.

7Space-Ready Smart Contact Lens
Categorystandalone application
Description

Smart contact lens incorporating a holographic display and biomedical sensors that integrate with a real space suit; the helmet-mounted image source powers the device and collects health metrics (intraocular pressure, glucose, vitamin levels, lactate) for astronauts operating in orbit, lunar, and deep-space missions.

8Passive Eye-Tracking Smart Contact Lens
Categorystandalone application
Description

Smart contact lens using moiré-pattern optical gratings (2.5 × 2.5 mm encapsulated in biocompatible silicone elastomer) that achieve approximately 0.3-degree gaze-tracking precision when read by standard cameras in laptops, dashboards, mobile devices, and helmets, with no need for infrared illumination or embedded power.

9Intracorneal Implant (with INTRA-KER)
Categoryjoint medtech product
Description

Joint XPANCEO/INTRA-KER implant that restores vision in patients with damaged or opaque corneas by projecting images directly onto the retina; combines INTRA-KER's patented intracorneal housing with XPANCEO's microdisplay and micro-optical projection system (450×450 pixels in a 5.6mm package), with visual data transmitted wirelessly from external smart glasses.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

French solid-state energy storage company ITEN and XPANCEO co-developed a proof-of-concept integrating ITEN's solid-state ceramic microbattery into a smart contact lens, addressing the fundamental power bottleneck of ocular wearables. ITEN has been mass-producing first-generation solid-state ceramic microbatteries since May 2025 and is customizing a battery for XPANCEO's specifications. The partnership was announced jointly on April 29, 2026.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Italian medtech startup INTRA-KER is co-developing with XPANCEO an intracorneal implant that bypasses the cornea and projects visual information directly onto the retina for patients with corneal blindness. Initial proof of concept combined a 450x450 pixel display with XPANCEO's micro-optical projection system in a 5.6mm package; testing was conducted with the Venice Eye Bank. XPANCEO plans to finalize a surgically implantable version for clinical trials over the next two years. INTRA-KER holds the patented intracorneal design IP.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MBRSC and XPANCEO are collaborating on a multi-stage testing program for the space-ready AR smart contact lens, including lab validation, ground simulations in low humidity / elevated oxygen / enclosed environments, parabolic flights for microgravity, biocompatibility and in-eye evaluations, and the potential for future in-orbit validation. The lens integrates with space suit systems to power the device, send visual data, and collect astronaut health metrics (IOP, glucose, vitamins, lactate).

Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Middlesex University Dubai (first overseas campus of Middlesex University London, in Dubai Knowledge Park) partnered with XPANCEO to host the open-lab event during GITEX Global 2025. Speakers from Middlesex University (Professor Fehmida Hussain, Dr. Engie Bashir) and from Cairns & Co Specialist Optometry Center (Zachary Cairns) joined XPANCEO scientists for a public lecture program bridging deep tech and academia.

Strategic tierCoreTypeGTM or Marketing Partner
Description

The Dubai Chamber of Digital Economy is showcasing XPANCEO alongside Carbon2Capital, Cognition AI, Kerno, and Qashio via its 'Launchpad Dubai' platform at GITEX AI Europe 2026 in Berlin (June 30 – July 1, 2026). The initiative aims to strengthen Dubai's digital-ecosystem positioning and connect Dubai-based innovators with European technology companies, investors, and startups.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

XPANCEO collaborates with the University of Manchester on material science and optics research, alongside Nobel laureate Konstantin Novoselov who maintains an affiliation there.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

XPANCEO collaborates with the National University of Singapore on advanced materials and nanophotonics research. Nobel laureate Sir Konstantin Novoselov, who chairs XPANCEO's Scientific Advisory Board, is a Professor at NUS.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

XPANCEO collaborates with the Donostia International Physics Center on materials science and optics research. Scientific Advisory Board member Prof. Luis Martin-Moreno of the University of Zaragoza is also affiliated through this network.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

XPANCEO collaborates with the University of Dubai as part of its research network in material science and optics.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Magic Leap develops AR headsets and spatial computing platforms targeting enterprise and eventually consumer use cases — overlapping with XPANCEO's broader AR/XR computing ambitions but in a head-mounted rather than contact-lens form factor.

TypeDirect peer
Description

Innovega develops iOptik smart contact lenses paired with smart glasses for AR/VR applications, overlapping directly with XPANCEO's AR vision and contact-lens form factor, though it relies on eyewear-coupled optics rather than a standalone lens.

TypeBroad incumbent
Description

Verily (formerly Google Life Sciences) developed a glucose-sensing smart contact lens in partnership with Novartis/Alcon and continues to operate in digital health and ophthalmic technologies; as an Alphabet subsidiary it represents the deep-pocketed incumbent most capable of fast-following XPANCEO's medical smart-lens thesis.

TypeBroad incumbent
Description

Meta's Reality Labs is investing tens of billions into AR glasses (Orion) and VR/MR headsets aimed at replacing smartphones and PCs as the next computing platform — directly competing with XPANCEO's "invisible computing" thesis though in a glasses form factor.

5Sony Semiconductor Solutions
TypeOthers
Description

Sony is a leading supplier of micro-OLED and micro-LED microdisplays for AR/VR headsets and smart glasses; relevant to XPANCEO as a current or future supplier of the on-eye microdisplay module that anchors its AR vision prototypes.

6JBD (Jade Bird Display)
TypeOthers
Description

JBD is the Chinese MicroLED firm that is already an XPANCEO supplier/partner for microdisplay components; comparable as a key enabling-technology provider in the same smart-lens and AR optics supply chain.

TypeDirect peer
Description

Mojo Vision is the most direct historical competitor in AR smart contact lenses; it built a micro-LED-enabled Mojo Lens with eye-tracking and has been pursuing similar consumer and medical use cases (vision augmentation, health monitoring), making it the closest analog despite its recent pivot toward micro-LED display technology.

TypeBroad incumbent
Description

Samsung Display is a leading micro-LED and OLED microdisplay manufacturer and a key potential supplier/competitor for the microdisplay module that XPANCEO currently sources from JBD; it could either partner with or compete against XPANCEO in future consumer smart-lens displays.

TypeDirect peer
Description

Sensimed's Triggerfish is a CE-marked smart contact lens for continuous 24-hour intraocular pressure monitoring in glaucoma — the same glaucoma-self-monitoring use case that XPANCEO targets with its AI-powered IOP sensor and smartphone app.

TypeBroad incumbent
Description

Apple's Vision Pro and long-rumored smart-glasses/AR lens programs place it as the dominant incumbent pursuing AR-as-next-computing-platform; XPANCEO's smart contact lens roadmap is a direct competitive response to Apple's eventual invisible-computing play.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

XPANCEO

Smart Contact Lens Wearablesxpanceo.com

XPANCEO is a Dubai-based deep-tech company developing a smart contact lens that fuses AR display, biometric biosensing, wireless power, and AI into a single invisible computing platform, currently targeting medical, aerospace, defense, and industrial enterprise customers with planned consumer availability in the early 2030s.

What XPANCEO does

XPANCEO is a Dubai-headquartered deep-tech company, founded in 2021 by Roman Axelrod and Dr. Valentyn S. Volkov, that is developing a smart contact lens as a single invisible computing platform integrating AR/XR display, biometrics, biosensing, night vision, color correction, and wireless power. Its technical stack combines proprietary 2D/quasi-2D gold transparent conductors, van der Waals and 2D nanophotonic materials, electrochemical tear-fluid biosensors, a custom high-efficiency on-body antenna paired with a compact companion device, and an integrated solid-state microbattery co-developed with France-based ITEN. On top of the platform architecture, XPANCEO is fielding standalone application lenses for glaucoma management (with an AI model trained on 10,000+ IOP measurements), medicine-level tear diagnostics for cancer and thrombosis, holographic AR vision for frontier environments, color-blindness correction, biometric authentication, passive moiré-pattern eye-tracking (~0.3° precision), and an intracorneal retinal projection implant co-developed with Italy-based INTRA-KER for corneal-blindness patients.

The company is currently pre-revenue, with commercial sales not yet started. Go-to-market is event-driven (MWC Barcelona, VivaTech Paris, GITEX Global Dubai, GITEX AI Europe Berlin) and partnership-driven in the near term, with a planned B2B/enterprise motion first targeting medical, aerospace, defense, and industrial customers by 2028, followed by a direct-to-consumer launch of the all-in-one smart contact lens in the early 2030s (most recently cited as 2033–2035). XPANCEO has raised $290 million across two rounds (a $40M seed in October 2023 and a $250M Series A in July 2025, both led by Opportunity Venture (Asia)) at a $1.35 billion unicorn valuation, employs 100+ scientists and engineers (more than half PhDs), and has filed 50+ patent applications alongside 300+ peer-reviewed publications. A Scientific Advisory Board chaired by Nobel Laureate Sir Konstantin Novoselov provides scientific oversight, and a multi-stage validation collaboration with the Mohammed Bin Rashid Space Centre (MBRSC) is underway.

XPANCEO firmographics

Firmographics
Name
XPANCEO
Legal name
XPANCEO Research On Natural Science L.L.C. S.O.C.
Website
https://xpanceo.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
51–100 employees
Short description
XPANCEO is a Dubai-based deep-tech company developing a smart contact lens that fuses AR display, biometric biosensing, wireless power, and AI into a single invisible computing platform, currently targeting medical, aerospace, defense, and industrial enterprise customers with planned consumer availability in the early 2030s.
Ownership category
akta.pro rank

XPANCEO industry classification

Industry
Product category
Smart Contact Lens Wearables
NAICS
Ophthalmic Goods Manufacturing (339115), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Ophthalmic Goods (3851), Optical Instruments & Lenses (3827), Electromedical & Electrotherapeutic Apparatus (3845), Measuring & Controlling Devices, Nec (3829)
akta.pro industry
PRIMARYHLAHAJAE
Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLAHAJAF
Dry Eye & Ocular Surface Devices (Meibography, Tear Osmolarity, IPL, Thermal Pulsation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLAHAJAI
Glaucoma Diagnostics & Surgical Devices (Tonometry, Gonioscopy, MIGS, Drainage Implants, Laser Trabeculoplasty)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLAHAJAN
Low Vision & Assistive Vision Devices (Magnifiers, Electronic Video Magnifiers, Wearable Vision Aids)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHDACALAH
Wearable Computers (Industrial Smart Glasses/Wrist/Arm-Mount)
SECONDARYIMAGAJAF
Optoelectronic Components (LEDs, photodiodes, optocouplers, optical sensors)
Industrials, Manufacturing & Construction/Electrical Equipment & Industrial Electronics/Electronic Components for Industrial Applications (Passive/active components, industrial-grade modules)

Keywords

  • Smart contact lenses
  • Augmented reality wearables
  • Nanophotonic optics
  • Tear-fluid biosensing
  • Extended reality computing

Where XPANCEO is headquartered

Location

Headquarters

HQ city
Dubai
HQ country
United Arab Emirates
HQ region
Middle East

Offices4 records

Markets served

XPANCEO business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Future hardware sales (smart contact lenses): Primary planned future revenue stream via direct sale of smart contact lenses integrating AR/XR display, biometric health monitoring, night vision, zoom, and wireless charging. B2B business customers targeted by 2028 and broad consumer launch planned for the early 2030s (originally ~2030, later refined to 2033–2035 per company statements). XPANCEO is currently pre-revenue.
  2. Future intracorneal implant sales (with INTRA-KER): Future revenue opportunity from the XPANCEO/INTRA-KER intracorneal implant that projects images directly onto the retina for patients with corneal blindness. Estimated addressable market of $50–200 million annually, with planned clinical trials over the next two years.
  3. Licensing / IP out-licensing (potential): Long-term revenue potential from licensing the company's patent portfolio (50+ patents applied, including WO2024102024A1 on wearable optical devices and quasi-2D gold conductors) and underlying 2D-material/nanophotonic IP to adjacent industries. Currently pre-commercial.

Go-to-market motion4 records

Distribution channels5 records

Marketing channels9 records

XPANCEO product offering

Product offering

Core offering

XPANCEO develops an invisible, weightless smart contact lens platform that fuses five core enabling modules (on-eye microdisplay with proprietary optics, communication/companion module with custom high-efficiency antenna, solid-state microbattery with wireless recharging, electrochemical tear-fluid biosensing, and quasi-2D gold transparent flexible electronics) into a single AI-powered XR computing platform. On top of the platform, the company offers standalone smart contact lens applications for glaucoma management, medicine monitoring, AR vision in frontier environments, color correction, authentication, space operations, and passive eye-tracking, plus an intracorneal implant co-developed with INTRA-KER for corneal blindness patients.

Product overview

XPANCEO's offering is a platform-plus-modules architecture built around a single integrated smart contact lens — described as the ultimate invisible computing platform for the AI era — into which five core enabling technology modules are combined: the Microdisplay for Smart Contact Lenses (AR image projection), the Communication Module / Compact Companion (high-efficiency wireless data link and power management), the Microbattery (autonomous solid-state power with wireless recharging, co-developed with ITEN), the Health Monitoring Platform (electrochemical tear-fluid biosensing), and the Transparent Flexible Electronics (quasi-2D gold conductors). On top of this platform XPANCEO offers a portfolio of standalone, ready-to-deploy smart contact lens applications — the AI-powered Smart Contact Lens for Glaucoma Management, the Smart Contact Lens for Medicine Monitoring, the AR Vision Smart Contact Lens for Frontier Applications, the Smart Contact Lens for Color Correction, the Smart Contact Lens for Authentication, the Space-Ready Smart Contact Lens, and the Passive Eye-Tracking Smart Contact Lens — each addressing a specific high-value use case. The company has additionally co-developed an Intracorneal Implant with INTRA-KER for corneal-blindness patients, extending the same microdisplay and wireless protocols into a surgically implantable form factor. The integrated on-eye prototype combining display, power, connectivity, and sensing is scheduled for first public demonstration in early 2027, with business customers targeted by 2028 and consumer products projected for the early 2030s.

Differentiator

Problem solved

Functional benefit

Products and services

  • Smart Contact Lens Platform (XPANCEO Invisible Computing Platform) Unifying platform that combines the microdisplay, communication module, microbattery, health monitoring platform, and transparent flexible electronics into a single smart contact lens designed as the invisible computing platform for the AI era, integrating AR vision, real-time biometrics, wireless power, and AI.
  • Smart Contact Lens for Glaucoma Management AI-powered smart contact lens with an embedded intraocular pressure (IOP) optical-pattern sensor; users capture the pattern with a smartphone AI app to instantly assess eye pressure for continuous at-home glaucoma monitoring.
  • Smart Contact Lens for Medicine Monitoring Smart contact lens that, after a full day of wear, is placed in a container using advanced spectroscopy with custom-developed gold nanoparticles to detect medication traces in tear fluid without an invasive blood test, supporting personalized dosing in cancer and thrombosis therapies.
  • AR Vision Smart Contact Lens for Frontier Applications Smart contact lens with a holographic optical element paired with a helmet-mounted external image source, designed for space missions, aviation, and racing where face-worn devices are impractical; allows the eye to focus on the image without obstructing vision.
  • Smart Contact Lens for Color Correction Smart contact lens enhanced with specially developed 2D-material-based nanoparticles that help people with color blindness distinguish RGB spectra by modifying the optical properties of incoming light.
  • Smart Contact Lens for Authentication Demo smart contact lens supporting transaction authentication, retail and financial services verification, universal system access (vehicles, buildings, terminals), and credential verification for age & access validation, esports compliance, and critical ops clearance.
  • Space-Ready Smart Contact Lens Smart contact lens incorporating a holographic display and biomedical sensors that integrate with a real space suit; the helmet-mounted image source powers the device and collects health metrics (intraocular pressure, glucose, vitamin levels, lactate) for astronauts operating in orbit, lunar, and deep-space missions.
  • Passive Eye-Tracking Smart Contact Lens Smart contact lens using moiré-pattern optical gratings (2.5 × 2.5 mm encapsulated in biocompatible silicone elastomer) that achieve approximately 0.3-degree gaze-tracking precision when read by standard cameras in laptops, dashboards, mobile devices, and helmets, with no need for infrared illumination or embedded power.
  • Intracorneal Implant (with INTRA-KER) Joint XPANCEO/INTRA-KER implant that restores vision in patients with damaged or opaque corneas by projecting images directly onto the retina; combines INTRA-KER's patented intracorneal housing with XPANCEO's microdisplay and micro-optical projection system (450×450 pixels in a 5.6mm package), with visual data transmitted wirelessly from external smart glasses.

Companies that use XPANCEO

Customer profile

Segments6 records

Ideal customer profiles6 records

XPANCEO technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability9 records

Feature9 records

XPANCEO partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered flagship, core and minor.

  • ITEN (I-TEN S.A.)flagshipStrategic or Co-development PartnerFrench solid-state energy storage company ITEN and XPANCEO co-developed a proof-of-concept integrating ITEN's solid-state ceramic microbattery into a smart contact lens, addressing the fundamental power bottleneck of ocular wearables. ITEN has been mass-producing first-generation solid-state ceramic microbatteries since May 2025 and is customizing a battery for XPANCEO's specifications. The partnership was announced jointly on April 29, 2026.
  • INTRA-KERcoreStrategic or Co-development PartnerItalian medtech startup INTRA-KER is co-developing with XPANCEO an intracorneal implant that bypasses the cornea and projects visual information directly onto the retina for patients with corneal blindness. Initial proof of concept combined a 450x450 pixel display with XPANCEO's micro-optical projection system in a 5.6mm package; testing was conducted with the Venice Eye Bank. XPANCEO plans to finalize a surgically implantable version for clinical trials over the next two years. INTRA-KER holds the patented intracorneal design IP.
  • Mohammed Bin Rashid Space Centre (MBRSC)coreStrategic or Co-development PartnerMBRSC and XPANCEO are collaborating on a multi-stage testing program for the space-ready AR smart contact lens, including lab validation, ground simulations in low humidity / elevated oxygen / enclosed environments, parabolic flights for microgravity, biocompatibility and in-eye evaluations, and the potential for future in-orbit validation. The lens integrates with space suit systems to power the device, send visual data, and collect astronaut health metrics (IOP, glucose, vitamins, lactate).
  • Middlesex University DubaiminorImplementation/ SI/ Consulting PartnerMiddlesex University Dubai (first overseas campus of Middlesex University London, in Dubai Knowledge Park) partnered with XPANCEO to host the open-lab event during GITEX Global 2025. Speakers from Middlesex University (Professor Fehmida Hussain, Dr. Engie Bashir) and from Cairns & Co Specialist Optometry Center (Zachary Cairns) joined XPANCEO scientists for a public lecture program bridging deep tech and academia.
  • Dubai Chamber of Digital EconomycoreGTM or Marketing PartnerThe Dubai Chamber of Digital Economy is showcasing XPANCEO alongside Carbon2Capital, Cognition AI, Kerno, and Qashio via its 'Launchpad Dubai' platform at GITEX AI Europe 2026 in Berlin (June 30 – July 1, 2026). The initiative aims to strengthen Dubai's digital-ecosystem positioning and connect Dubai-based innovators with European technology companies, investors, and startups.
  • University of ManchesterminorStrategic or Co-development PartnerXPANCEO collaborates with the University of Manchester on material science and optics research, alongside Nobel laureate Konstantin Novoselov who maintains an affiliation there.
  • National University of SingaporeminorStrategic or Co-development PartnerXPANCEO collaborates with the National University of Singapore on advanced materials and nanophotonics research. Nobel laureate Sir Konstantin Novoselov, who chairs XPANCEO's Scientific Advisory Board, is a Professor at NUS.
  • Donostia International Physics CenterminorStrategic or Co-development PartnerXPANCEO collaborates with the Donostia International Physics Center on materials science and optics research. Scientific Advisory Board member Prof. Luis Martin-Moreno of the University of Zaragoza is also affiliated through this network.
  • University of DubaiminorStrategic or Co-development PartnerXPANCEO collaborates with the University of Dubai as part of its research network in material science and optics.

Scale indicators11 records

Recent moves7 records

Expansion highlights7 records

XPANCEO competitors and assessment

Company assessment

Emerging players

  • Magic Leap: Magic Leap develops AR headsets and spatial computing platforms targeting enterprise and eventually consumer use cases — overlapping with XPANCEO's broader AR/XR computing ambitions but in a head-mounted rather than contact-lens form factor.

Direct peers

  • Innovega: Innovega develops iOptik smart contact lenses paired with smart glasses for AR/VR applications, overlapping directly with XPANCEO's AR vision and contact-lens form factor, though it relies on eyewear-coupled optics rather than a standalone lens.
  • Mojo Vision: Mojo Vision is the most direct historical competitor in AR smart contact lenses; it built a micro-LED-enabled Mojo Lens with eye-tracking and has been pursuing similar consumer and medical use cases (vision augmentation, health monitoring), making it the closest analog despite its recent pivot toward micro-LED display technology.
  • Sensimed (Triggerfish): Sensimed's Triggerfish is a CE-marked smart contact lens for continuous 24-hour intraocular pressure monitoring in glaucoma — the same glaucoma-self-monitoring use case that XPANCEO targets with its AI-powered IOP sensor and smartphone app.

Broad incumbents

  • Verily (Alphabet): Verily (formerly Google Life Sciences) developed a glucose-sensing smart contact lens in partnership with Novartis/Alcon and continues to operate in digital health and ophthalmic technologies; as an Alphabet subsidiary it represents the deep-pocketed incumbent most capable of fast-following XPANCEO's medical smart-lens thesis.
  • Meta (Reality Labs): Meta's Reality Labs is investing tens of billions into AR glasses (Orion) and VR/MR headsets aimed at replacing smartphones and PCs as the next computing platform — directly competing with XPANCEO's "invisible computing" thesis though in a glasses form factor.
  • Samsung (MicroLED/Display): Samsung Display is a leading micro-LED and OLED microdisplay manufacturer and a key potential supplier/competitor for the microdisplay module that XPANCEO currently sources from JBD; it could either partner with or compete against XPANCEO in future consumer smart-lens displays.
  • Apple (Vision Products): Apple's Vision Pro and long-rumored smart-glasses/AR lens programs place it as the dominant incumbent pursuing AR-as-next-computing-platform; XPANCEO's smart contact lens roadmap is a direct competitive response to Apple's eventual invisible-computing play.

Others

  • Sony Semiconductor Solutions: Sony is a leading supplier of micro-OLED and micro-LED microdisplays for AR/VR headsets and smart glasses; relevant to XPANCEO as a current or future supplier of the on-eye microdisplay module that anchors its AR vision prototypes.
  • JBD (Jade Bird Display): JBD is the Chinese MicroLED firm that is already an XPANCEO supplier/partner for microdisplay components; comparable as a key enabling-technology provider in the same smart-lens and AR optics supply chain.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

XPANCEO social profiles

Digital presence

XPANCEO financial estimates

Financial estimate

Revenue estimate

Valuation estimate

XPANCEO leadership team

Management profile

Number of profiles

Profiles4 records

XPANCEO funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

XPANCEO M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about XPANCEO

What does XPANCEO do?

XPANCEO develops an invisible, weightless smart contact lens platform that fuses five core enabling modules (on-eye microdisplay with proprietary optics, communication/companion module with custom high-efficiency antenna, solid-state microbattery with wireless recharging, electrochemical tear-fluid biosensing, and quasi-2D gold transparent flexible electronics) into a single AI-powered XR computing platform. On top of the platform, the company offers standalone smart contact lens applications for glaucoma management, medicine monitoring, AR vision in frontier environments, color correction, authentication, space operations, and passive eye-tracking, plus an intracorneal implant co-developed with INTRA-KER for corneal blindness patients.

Is XPANCEO a public or private company?

XPANCEO is a private company. It is classified as venture growth investor backed and is currently operating.

When was XPANCEO founded?

XPANCEO was founded in 2021. It employs 51 to 100 people.

Where is XPANCEO based?

XPANCEO is headquartered in Dubai, United Arab Emirates, in the Middle East region.

How does XPANCEO make money?

Three revenue lines are on record. Future hardware sales (smart contact lenses) is the primary driver. The others are future intracorneal implant sales (with INTRA-KER) and licensing / IP out-licensing (potential).

Who are XPANCEO's main competitors?

Magic Leap is listed as an emerging player. Direct peers are Innovega, Mojo Vision and Sensimed (Triggerfish). Broad incumbents are Verily (Alphabet), Meta (Reality Labs), Samsung (MicroLED/Display) and Apple (Vision Products). Others are Sony Semiconductor Solutions and JBD (Jade Bird Display).

Does XPANCEO have an API?

No public API is recorded for XPANCEO.

What industry is XPANCEO in?

XPANCEO's product category is Smart Contact Lens Wearables. Its primary akta.pro industry code is HLAHAJAE, Contact Lenses & Care Systems (Soft/RGP/Scleral Lenses; Cleaning/Disinfection Solutions), with a secondary code of HLAHAJAF, Dry Eye & Ocular Surface Devices (Meibography, Tear Osmolarity, IPL, Thermal Pulsation). Its NAICS code is 339115 and its SIC code is 3851.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TechRoundYour Next Screen Could Be A Contact Lens – Are Smart Lenses the Future of Wearable Tech?Companies are developing smart contact lenses with sensors and displays, including XPANCEO's health-monitoring prototype and Mojo Vision's micro-LED screen. Triggerfish, an FDA-approved lens, detects eye pressure changes, while glucose tracking has failed due to inconsistent readings. No fully integrated smart lens is available for mainstream use yet.Unite.AIXPANCEO and JBD Move Smart Contact Lenses Closer to Commercial Reality With Custom Micro-DisplayXPANCEO and JBD have announced the next phase of their collaboration to co-develop a custom micro-display specifically designed for integration into XPANCEO's smart contact lens platform, addressing the extreme engineering constraints of building a display thin enough to sit on the eye. The companies are working to solve critical optical and power efficiency challenges, including creating projection optics that allow the human eye to focus on an image positioned directly on its surface and developing a specialized backplane optimized for ultra-low-current operation. XPANCEO has filed over 50 patents and assembled a Dubai-based R&D team of more than 100 scientists as it positions itself to move from prototype demonstration toward establishing the first mass-market production run of specialized contact lens micro-displays.Road to VRSmart Contact Lenses Move Closer to Reality as XPANCEO Expands JBD Display PartnershipDubai-based smart contact lenses startup XPANCEO announced it is expanding its partnership with Shanghai-based micro display company JBD to co-develop micro-displays specifically designed for smart contact lenses, building on their previous work on printed circuit boards and near-eye imaging optical systems. The expanded partnership will focus on scalability and manufacturability to enable mass-market production of contact lens microdisplays, with key technical challenges including fitting components to the thickness of a human hair and managing brightness levels for ocular safety. XPANCEO secured $250 million in Series A financing in July 2025, valuing the company at $1.35 billion.ZawyaXPANCEO and JBD take AR to the next level with custom micro-display for smart contact lensesXPANCEO and JBD are co-developing a custom micro-display for smart contact lenses, building on prior proof-of-concept work. The display must be ultra-thin, low-power, and safe for ocular use, with a diameter under a fraction of a millimeter. The partnership aims to achieve the first mass-market production run of such displays.VrWhile Everyone Fights Over AR Glasses, Two Companies Are Building the Display for What Comes Next: Contact Lenses.XPANCEO, a Dubai startup, and JBD, a Chinese microLED display maker, have entered the next phase of their collaboration to co-develop a micro-display specifically designed for smart contact lenses, having already produced a working prototype under half a millimeter thick. The display consumes under 10 microwatts of power—100 to 300 times less than comparable AR glasses would require—addressing the fundamental power and size constraints that make contact lens computing so challenging. The companies have shifted focus to scalability and manufacturability, aiming to establish the first mass-market production run of specialized contact lens microdisplays, marking a transition from prototype to potential product roadmap.Auganix.orgXPANCEO and JBD Co-Develop AR Contact Lens Micro-DisplayXPANCEO and JBD have entered the second phase of their collaboration to co-develop a custom micro-display specifically designed for integration into AR-enabled smart contact lenses. During the proof-of-concept stage, the companies created a PCB with an integrated micro-display, developed an optical system for comfortable eye focusing, and demonstrated wireless power capability, with the resulting display expected to measure less than a millimeter in diameter. The partnership aims to establish the first mass-market production run of specialized contact lens micro-displays, addressing key technical hurdles around display size, power consumption, and optical comfort that have limited commercial readiness of smart contact lens technology.Tech.euVivaTech 2026 marks its 10th anniversary with a record-breaking editionVivaTech 2026, held June 17-20, 2026, set a record with over 200,000 visitors from 165 nationalities. The event featured 1,155 speakers, 60 country pavilions, and 15,000 startups, with a cumulative social media audience exceeding 5 billion. The 10th anniversary edition opened the next decade of innovation.INTLBMUAE Boosts Initiatives to Develop AI Unicorn CompaniesThe UAE is aggressively pursuing its goal to become a global AI hub through the National AI Strategy 2031, which includes plans to cultivate 30 unicorn companies by 2030 under the "Unicorn 30" initiative. The Emirates currently hosts three AI unicorns—G42 (valued at $23 billion with Microsoft backing), Xpanceo ($1.35 billion valuation after a $250 million Series A), and AI.Tech ($1.5 billion valuation)—alongside approximately 800 AI companies in Dubai and 673 in Abu Dhabi. The UAE's AI market is projected to grow from $3.47 billion in 2023-2024 to $46.33 billion by 2030, with the country capturing 60% of total MENA-region AI funding.The Daily StarThis startup wants to turn contact lenses into wearable computersXPANCEO, a Dubai-based technology startup, announced it created a proof of concept for integrating a microbattery into smart contact lenses in partnership with France-based ITEN, a milestone addressing one of the key technical challenges for wearable contact lens computers. The company also revealed it raised $250 million in Series A funding in July 2025, valuing XPANCEO at $1.35 billion and granting it unicorn status, with both funding rounds led by Opportunity Venture (Asia). XPANCEO is targeting around 2030 for potential commercial availability of its smart contact lenses capable of displaying augmented reality, monitoring health data, and providing wireless connectivity, though significant technical and regulatory hurdles remain.Glass AlmanacWe Are Constructing The Way To Interact Sparks Safety Questions In 2026 – Here’s WhyXpanceo, a Dubai-based startup, has publicly claimed its atom-thin smart contact lenses will serve as an AI interface embedded in human perception rather than a simple display, targeting consumer readiness by 2030. The company raised $250 million in Series A funding in 2025 to scale optics, power, and biosensing capabilities. Regulators, medical-device reviewers, and privacy advocates are now demanding clinical trial data, biocompatibility evidence, and manufacturing yield proof before considering the product viable beyond prototype stage.